{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/sepsis/background-information/complications/","result":{"pageContext":{"chapter":{"id":"88dcfc30-9b7f-5f3e-8dc9-6f5bb11802f3","slug":"complications","fullItemName":"Complications","depth":2,"htmlHeader":"<!-- begin field bab97a99-51dd-4933-a687-aa4c00f3c9d7 --><h2>What are the complications?</h2><!-- end field bab97a99-51dd-4933-a687-aa4c00f3c9d7 -->","summary":"","htmlStringContent":"<!-- begin item 45b8cc70-54bb-4c16-aceb-aa4c00f3c9b3 --><!-- begin field 38c75d2c-f956-47b5-ae0f-aa4c00f3c9d8 --><p><strong>Sepsis is a leading cause of morbidity and mortality. Between one-fifth and one-half of sepsis survivors following hospital admission experience long-term sequelae ('Post-Sepsis Syndrome'). Possible complications of sepsis include </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">NHS England, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Daniels, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Rhodes, 2017</a>]<strong>:</strong></p><ul><li>Death<ul><li>Sepsis is the leading cause of avoidable death from infection, and 25–30% of people with sepsis die from the condition [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Singer, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Cecconi, 2018</a>].</li><li>In 2001–10, 5.1% of deaths in England were associated with sepsis, according to an observational study of cause of death data extracted from the Office for National Statistics mortality database [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">McPherson, 2013</a>].<ul><li>The death rate in 2010 was higher for males (29.8 deaths per 100,000 population) compared with females (24.8 deaths per 100,000 population).</li><li>Age-specific mortality rates were higher at the extremes of age, with the rate in infants under one year being similar to that in people aged 60 years and over.</li></ul></li><li>The UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2014–16 notes that sepsis is the leading direct cause of maternal death in the UK [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Knight, 2018</a>].</li></ul></li><li>Organ failure<ul><li>This may be multi-system and includes acute kidney injury (AKI), cholestasis, heart failure, acute respiratory distress syndrome (ARDS) or acute lung injury, and bone marrow suppression [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Gotts, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Cecconi, 2018</a>]. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/acute-kidney-injury/\">Acute kidney injury</a>, <a class=\"topic-reference external-reference\" href=\"/topics/jaundice-in-adults/\">Jaundice in adults</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/heart-failure-chronic/\">Heart failure - chronic</a> for more information.<ul><li>Up to 60% of people with sepsis have AKI, which is an independent risk factor for mortality [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Poston, 2019</a>].</li></ul></li></ul></li><li>Recurrent and secondary infection<ul><li>People who survive early sepsis may develop hospital-acquired infections with atypical organisms, and may have reactivation of latent viruses, due to an impaired ability to mount an appropriate immune response to superadded infections [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Gotts, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Cecconi, 2018</a>].</li><li>Recurrent infections may be due to immunosuppression from a persistent compensatory anti-inflammatory response [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Daniels, 2017</a>].</li></ul></li><li>Malnutrition<ul><li>This may be partly due to impaired intestinal barrier function [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Gotts, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Daniels, 2017</a>].</li></ul></li><li>Coagulopathy<ul><li>This may cause thromboembolism or disseminated intravascular coagulation (DIC) characterized by microthrombosis and haemorrhage [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Cecconi, 2018</a>]. Microvascular changes and DIC can result in loss of digits or limbs [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Daniels, 2017</a>]. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/deep-vein-thrombosis/\">Deep vein thrombosis</a> and <a class=\"topic-reference external-reference\" href=\"/topics/pulmonary-embolism/\">Pulmonary embolism</a> for more information.</li></ul></li><li>Physical impairments<ul><li>A reduced quality of life may result from chronic pain and fatigue [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Winters, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Gauer, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Daniels, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Cecconi, 2018</a>].</li></ul></li><li>Encephalopathy and delirium<ul><li>This may lead to reduced mobility and neuromuscular weakness, as well as longer lasting neurocognitive deficits such as memory problems and reduced concentration [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Daniels, 2017</a>]. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/delirium/\">Delirium</a> for more information.</li></ul></li><li>Psychological sequelae<ul><li>These may include anxiety about recurrent infection and sepsis, post-traumatic stress disorder, loss of confidence and self-esteem [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Gauer, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Daniels, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Cecconi, 2018</a>]. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/generalized-anxiety-disorder/\">Generalized anxiety disorder</a> and <a class=\"topic-reference external-reference\" href=\"/topics/post-traumatic-stress-disorder/\">Post-traumatic stress disorder</a> for more information.</li></ul></li></ul><!-- end field 38c75d2c-f956-47b5-ae0f-aa4c00f3c9d8 --><!-- end item 45b8cc70-54bb-4c16-aceb-aa4c00f3c9b3 -->","topic":{"id":"6934ac75-4c45-5f2f-8c9a-2d8851f1adf5","topicId":"eab5610a-80e3-49d5-ac25-aa0600a5625f","topicName":"Sepsis","slug":"sepsis","lastRevised":"Last revised in April 2020","chapters":[{"id":"21403d5c-7f6a-58f8-a754-f80facfcc7b7","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"01bfd22f-a788-595c-9d77-4f15e7d21471","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"8280962c-6cb2-53a1-8eed-ec18c19db62a","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"02ea2408-9b6e-5954-a3bc-8305ad7c2b3d","slug":"changes","fullItemName":"Changes"},{"id":"c2a838a7-45f2-5a2b-8e94-13f83b057517","slug":"update","fullItemName":"Update"}]},{"id":"a1a6b520-0d3e-5568-8fcf-e882ce604048","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"a9d2a1af-b338-5209-93b4-bddc7b6b5cbd","slug":"goals","fullItemName":"Goals"},{"id":"b2606ff0-0e97-55b2-83e3-4b0c5d0a2be2","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"3c4a84a7-c8f8-551b-bf15-639adaa8882d","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"af6a0131-ac12-5bf9-9ae2-5a74b2adbde7","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"379dd412-6848-5408-bbec-b555f59bfc67","slug":"qipp","fullItemName":"QIPP"},{"id":"cae1293c-e888-54e5-a1dd-6f9b76935048","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"e59cb5ea-715e-5c86-a9eb-1321bb0a362f","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"6ca10715-009f-5d48-ae98-5f1104993328","slug":"definition","fullItemName":"Definition"},{"id":"25449018-76ee-5a28-ba72-210726d864df","slug":"causes","fullItemName":"Causes"},{"id":"2e720b24-f767-5b2a-98e1-3cac09695ebc","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"fe40a4b7-90d6-5125-8498-68e555cda754","slug":"prevalence","fullItemName":"Prevalence"},{"id":"88dcfc30-9b7f-5f3e-8dc9-6f5bb11802f3","slug":"complications","fullItemName":"Complications"},{"id":"5dbce53d-7615-52d2-9cb1-c0464ff30dbb","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"96778028-ae23-5d58-96db-6778ae09539c","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"31213219-a7d3-56db-9cfe-497952324a5b","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"fcf9d6d1-de70-585a-872d-39f4a36dd779","slug":"assessment","fullItemName":"Assessment"},{"id":"01c98f9e-2c4f-5551-96f8-b3842afc11ed","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"75ccb28e-2583-5018-b95b-9534f5c406cf","fullItemName":"Management","slug":"management","subChapters":[{"id":"e40708e7-39fd-5446-9536-8cf4c01bc2a9","slug":"management","fullItemName":"Scenario: Management"},{"id":"34acc039-3bd9-55d2-86cd-3425bafcb304","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"c0cc5534-3a65-5215-b06f-82d0952f8728","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"78019898-1022-5b3f-bced-95df62a87a55","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"7d6600d7-11ae-522d-8267-927494750ab2","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"47e69ad2-af94-5cf1-9cb9-9a765667697b","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b93e807a-0902-5c86-be52-22d6b24c8c21","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"74decb37-dae1-574b-b0d6-e9fd1505b280","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"df2e239f-4f1b-5ef3-8d0a-47b08ab0e887","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"dd29e46f-df2c-5e1c-b46a-1b6d3a95edbe","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"e59cb5ea-715e-5c86-a9eb-1321bb0a362f","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}